Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00593281 | INFUSE Morphine Study | PHASE3 | COMPLETED | 13 | — | — | Jan 1, 2006 | Oct 1, 2006 | Jan 14, 2008 | 2 | United States |
| Arm | Type | Description |
|---|---|---|
| 1 | NO_INTERVENTION | IV Morphine |
| 2 | EXPERIMENTAL | SC Morphine with Hylenex |
| 3 | ACTIVE_COMPARATOR | SC Morphine with Saline |
| Name | Type | Description |
|---|---|---|
| Hylenex | DRUG | Add Hylenex to SC injection of Morphine |
Inclusion Criteria: 1. Males or females at least 18 years of age who are patients of San Diego Hospice \& Palliative Care or recruited through San Diego Hospice \& Palliative Care or the UCSD Center for Pain and Palliative Medicine. 2. During the treatment days of the study, on opioid therapy other...